Sodium (6R,7S)-7-({N-[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]-D-threonyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate(CAS: 76648-01-6)

This compound is a crystalline solid with a molecular weight of approximately 1012.5 g/mol. It is slightly soluble in water and organic solvents. Chemically, it is reactive towards nucleophiles and can undergo hydrolysis under basic conditions. It exhibits good stability under neutral to slightly acidic conditions.

This compound is typically synthesized via a multi-step process involving peptide coupling, tetrazole formation, and methylation. Key steps include the condensation of D-threonyl-D-alanine with a protected piperazine derivative, followed by the installation of a tetrazole group and methylation at the appropriate position.

This compound finds applications in the pharmaceutical industry, particularly in the development of novel therapeutic agents. Its unique chemical structure allows for the design of molecules with specific biological activities, making it valuable for drug discovery and synthesis.

When handling this compound, it is essential to use appropriate Personal Protective Equipment (PPE), including gloves and goggles. Ensure that the work is conducted in a well-ventilated fume hood to minimize inhalation exposure. Spills should be cleaned up using appropriate absorbent materials and disposed of according to local regulations. Always consult the Safety Data Sheet (SDS) for detailed safety information.